Survey: Consumers Hold Drug Companies Responsible for High Prices and Out-of-Pocket Costs
November 30, 2016
A new national survey finds most voters blame drug companies not only for high drug prices, also for out-of-pocket costs...
Filter by:
Drug Cost Management
Filter by Year:Clear Filters- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
The Return on Investment (ROI) on PBM Services
November 21, 2016
An analysis from Visante quantifying how PBMs generate $6 in savings for each $1 spent on their services. Major Findings...
Medicaid Pharmacy Savings Opportunities: National and State-Specific Estimates
October 13, 2016
Executive Summary This study examines whether the full range of pharmacy benefit management (PBM) tools are being allowed and used...
Report: Comparison of Hepatitis C Treatment Costs
September 23, 2016
A report from IMS Institute for Healthcare Informatics shows Hepatitis C drug prices, specifically negotiated by pharmacy benefit managers (PBMs)...
September 21, 2016
EpiPen prices far outpace cost sharing: Mylan has increased their list price from $100 in 2009 to over $600 in...
North Star Survey of Business Owners and Executives
September 13, 2016
This survey of 400 small business owners and medium-to-large business executives, conducted online July 26-29, 2016, shows that business leaders...